PATENT CLAIM ANALYSIS

Application Number: 16148028
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["514", "289000"]

Abstract:
This disclosure provides pharmaceutical compositions comprising dextromethorphan in combination with quinidine, and methods for treating agitation and/or aggression in subjects with dementia by administering such compositions.

Claim (Index 2):
The method of  claim 1 , wherein dextromethorphan is administered in an amount ranging from about 10 mg to about 200 mg per day, and wherein quinidine is administered in an amount ranging from about 0.05 mg to less than about 50 mg per day.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 97.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13415067', '11035213', '15211638', '14100597', '12080756']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7612148949679909
- 35 USC 102 Novelty (BERT): 0.5301840435553251
- Combined Prediction Score: 0.7381118098267243
- Mean Citation Score: 284.692826
- Max Citation Score: 352.63284
- Similarity Product: 276.1098926008773

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test